Recent investigations have increasingly underscored the role of fibrinogen—a key glycoprotein integral to blood coagulation—as a potential independent biomarker in cancer prognosis. Elevated plasma ...
FDA Approves New Fibrinogen Concentrate for Congenital Fibrinogen Deficiency ...
The FDA has approved a new fibrinogen concentrate — fibrinogen, human-chmt (Fesilty, Grifols Therapeutics, LLC) — for the treatment of acute bleeding episodes in pediatric and adult patients with ...